For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
LEVOTHYROXINE (SODIUM): products 1 to 20 of 28.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Levothyroxine 0.025mg TabDIN 02550709 | General benefit | $0.0597per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.05mg TabDIN 02550717 | General benefit | $0.0373per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.075mg TabDIN 02550725 | General benefit | $0.0646per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.088mg TabDIN 02550733 | General benefit | $0.0646per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.112mg TabDIN 02550741 | General benefit | $0.0682per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.125mg TabDIN 02550768 | General benefit | $0.0690per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.137mg TabDIN 02550776 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.15mg TabDIN 02550784 | General benefit | $0.0495per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.175mg TabDIN 02550792 | General benefit | $0.0740per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.1mg TabDIN 02534681 | General benefit | $0.0460per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.2mg TabDIN 02550806 | General benefit | $0.0526per source unit | Requirements & sourcesBuild cost plan |
| Apo-Levothyroxine 0.3mg TabDIN 02534703 | General benefit | $0.0797per source unit | Requirements & sourcesBuild cost plan |
| Eltroxin 0.05mg TabDIN 02213192 | General benefit | $0.0373per source unit | Requirements & sourcesBuild cost plan |
| Eltroxin 0.15mg TabDIN 02213214 | General benefit | $0.0495per source unit | Requirements & sourcesBuild cost plan |
| Eltroxin 0.1mg TabDIN 02213206 | General benefit | $0.0460per source unit | Requirements & sourcesBuild cost plan |
| Eltroxin 0.2mg TabDIN 02213222 | General benefit | $0.0526per source unit | Requirements & sourcesBuild cost plan |
| Synthroid 0.025mg TabDIN 02172062 | General benefit | $0.0597per source unit | Requirements & sourcesBuild cost plan |
| Synthroid 0.05mg TabDIN 02172070 | General benefit | $0.0373per source unit | Requirements & sourcesBuild cost plan |
| Synthroid 0.075mg TabDIN 02172089 | General benefit | $0.0646per source unit | Requirements & sourcesBuild cost plan |
| Synthroid 0.088mg TabDIN 02172097 | General benefit | $0.0646per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives